Lilly’s Triple-G Obesity Drug Clears First Late-Stage Diabetes TrialBusiness PenMarch 19, 2026 March 19, 2026 Eli Lilly and Company (NYSE: LLY) has produced fresh data that could widen its lead in the race to dominate both obesity and type 2...
